Signaling lymphocytic activation molecules Slam and cancers: friends or foes?

Signaling Lymphocytic Activation Molecules (SLAM) family receptors are initially described in immune cells. These receptors recruit both activating and inhibitory SH2 domain containing proteins through their Immunoreceptor Tyrosine based Switch Motifs (ITSMs). Accumulating evidence suggest that the...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Fouquet, Gregory, Marcq, Ingrid, Debuysscher, Véronique, Bayry, Jagadeesh, Rabbind Singh, Amrathlal, Bengrine, Abderrahmane, Nguyen-Khac, Eric, Naassila, Mickael, Bouhlal, Hicham
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2018
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5882332/
https://ncbi.nlm.nih.gov/pubmed/29662641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24575
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia